SODIUM CHLORIDE 0.9 % INTRAVENOUS INFUSION BP Israel - English - Ministry of Health

sodium chloride 0.9 % intravenous infusion bp

teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

CALCIUM RESONIUM calcium polystyrene sulfonate powder can Australia - English - Department of Health (Therapeutic Goods Administration)

calcium resonium calcium polystyrene sulfonate powder can

sanofi-aventis australia pty ltd - calcium polystyrene sulfonate, quantity: 999.3 mg/g - powder - excipient ingredients: vanillin; saccharin - calcium resonium is an ion-exchange resin. it is recommended for the treatment of hyperkalaemia associated with anuria and severe oliguria.,it is also used to treat hyperkalaemia in patients requiring dialysis and in patients on regular haemodialysis or on prolonged peritoneal dialysis.

SODIUM VALPROATE WOCKHARDT sodium valproate 1000 mg/10 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

sodium valproate wockhardt sodium valproate 1000 mg/10 ml solution for injection ampoule

wockhardt bio pty ltd - sodium valproate, quantity: 1000 mg - injection, solution - excipient ingredients: dibasic sodium phosphate dodecahydrate; monobasic sodium phosphate dihydrate; phosphoric acid; sodium hydroxide; water for injections - sodium valproate wockhardt is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

SODIUM VALPROATE WOCKHARDT sodium valproate 400 mg/4 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

sodium valproate wockhardt sodium valproate 400 mg/4 ml solution for injection ampoule

wockhardt bio pty ltd - sodium valproate, quantity: 400 mg - injection, solution - excipient ingredients: dibasic sodium phosphate dodecahydrate; monobasic sodium phosphate dihydrate; phosphoric acid; sodium hydroxide; water for injections - sodium valproate wockhardt is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

SOLYSTAT POWDER FOR SUSPENSION Canada - English - Health Canada

solystat powder for suspension

pendopharm division of pharmascience inc - sodium polystyrene sulfonate - powder for suspension - 1g - sodium polystyrene sulfonate 1g - potassium-removing agents

SOLYSTAT SUSPENSION Canada - English - Health Canada

solystat suspension

pendopharm division of pharmascience inc - sodium polystyrene sulfonate - suspension - 250mg - sodium polystyrene sulfonate 250mg - potassium-removing agents

SOLYSTAT SUSPENSION Canada - English - Health Canada

solystat suspension

pendopharm division of pharmascience inc - sodium polystyrene sulfonate - suspension - 250mg - sodium polystyrene sulfonate 250mg - potassium-removing agents

KAYEXALATE POWDER FOR SUSPENSION Canada - English - Health Canada

kayexalate powder for suspension

sanofi-aventis canada inc - sodium polystyrene sulfonate - powder for suspension - 1g - sodium polystyrene sulfonate 1g - potassium-removing agents

SODIUM CHLORIDE 0.9 % INTRAVENOUS INFUSION BP Israel - English - Ministry of Health

sodium chloride 0.9 % intravenous infusion bp

teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.